GENERAL17 Sept 2026
Centre asks states, UTs to clamp down on stem cell therapy for autism care
The Health Ministry has told states and union territories to crack down on stem cell therapy being used to treat autism. Such treatment must stay limited to approved clinical trials only. Anyone offering it outside these trials could face regulatory and disciplinary action. So if your clinic or a family member is considering this therapy, check first that it is part of an approved trial.
Key Statutory Highlights
- The Health Ministry says stem cell therapy for autism must remain restricted to approved clinical trials.
- Unauthorised use of this therapy could invite regulatory and disciplinary action.
- States and union territories have been asked to clamp down on such unauthorised use.
Actionable Advice for Taxpayers / Founders:If you or your clinic offers or is considering stem cell therapy for autism, confirm with the treating doctor that it forms part of an approved clinical trial before going ahead.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: